These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32036613)

  • 1. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
    Commons RJ; McCarthy JS; Price RN
    Med J Aust; 2020 Mar; 212(4):152-153.e1. PubMed ID: 32036613
    [No Abstract]   [Full Text] [Related]  

  • 2. Tafenoquine and G6PD: a primer for clinicians.
    Chu CS; Freedman DO
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Sex-Stratified
    Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
    Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
    Recht J; Ashley EA; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (
    Rueangweerayut R; Bancone G; Harrell EJ; Beelen AP; Kongpatanakul S; Möhrle JJ; Rousell V; Mohamed K; Qureshi A; Narayan S; Yubon N; Miller A; Nosten FH; Luzzatto L; Duparc S; Kleim JP; Green JA
    Am J Trop Med Hyg; 2017 Sep; 97(3):702-711. PubMed ID: 28749773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
    Beutler E; Duparc S;
    Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tafenoquine: a toxicity overview.
    Chu CS; Hwang J
    Expert Opin Drug Saf; 2021 Mar; 20(3):349-362. PubMed ID: 33306921
    [No Abstract]   [Full Text] [Related]  

  • 10. Approval of Tafenoquine for Malaria Chemoprophylaxis.
    Berman JD
    Am J Trop Med Hyg; 2019 Jun; 100(6):1301-1304. PubMed ID: 30887947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
    von Seidlein L; Auburn S; Espino F; Shanks D; Cheng Q; McCarthy J; Baird K; Moyes C; Howes R; Ménard D; Bancone G; Winasti-Satyahraha A; Vestergaard LS; Green J; Domingo G; Yeung S; Price R
    Malar J; 2013 Mar; 12():112. PubMed ID: 23537118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.
    Uthman OA; Saunders R; Sinclair D; Graves P; Gelband H; Clarke A; Garner P
    BMJ Open; 2014 May; 4(5):e004664. PubMed ID: 24833685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tafenoquine: the new kid on the block.
    Chen V; Daily JP
    Curr Opin Infect Dis; 2019 Oct; 32(5):407-412. PubMed ID: 31305490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
    Thriemer K; Ley B; Bobogare A; Dysoley L; Alam MS; Pasaribu AP; Sattabongkot J; Jambert E; Domingo GJ; Commons R; Auburn S; Marfurt J; Devine A; Aktaruzzaman MM; Sohel N; Namgay R; Drukpa T; Sharma SN; Sarawati E; Samad I; Theodora M; Nambanya S; Ounekham S; Mudin RN; Da Thakur G; Makita LS; Deray R; Lee SE; Boaz L; Danansuriya MN; Mudiyanselage SD; Chinanonwait N; Kitchakarn S; Nausien J; Naket E; Duc TN; Do Manh H; Hong YS; Cheng Q; Richards JS; Kusriastuti R; Satyagraha A; Noviyanti R; Ding XC; Khan WA; Swe Phru C; Guoding Z; Qi G; Kaneko A; Miotto O; Nguitragool W; Roobsoong W; Battle K; Howes RE; Roca-Feltrer A; Duparc S; Bhowmick IP; Kenangalem E; Bibit JA; Barry A; Sintasath D; Abeyasinghe R; Sibley CH; McCarthy J; von Seidlein L; Baird JK; Price RN
    Malar J; 2017 Apr; 16(1):141. PubMed ID: 28381261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
    Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.
    Leslie T; Moiz B; Mohammad N; Amanzai O; Ur Rasheed H; Jan S; Siddiqi AM; Nasir A; Beg MA; Vink M
    Malar J; 2013 Jul; 12():230. PubMed ID: 23834949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.